Cargando…
Cutaneous Eruption due to Telaprevir
Hepatitis C virus (HCV) chronically infects 0.5–3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effects of these drugs is skin eruption. We report a 53...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612548/ https://www.ncbi.nlm.nih.gov/pubmed/26500538 http://dx.doi.org/10.1159/000439264 |
_version_ | 1782396186472218624 |
---|---|
author | Falcão, Eduardo Mastrangelo Marinho Trope, Beatriz Moritz Godinho, Mariana Marteleto Carneiro, Leonardo Hoehl de Araujo-Neto, João Marcello Nogueira, Cristiane Alves Villela Ramos-e-Silva, Marcia |
author_facet | Falcão, Eduardo Mastrangelo Marinho Trope, Beatriz Moritz Godinho, Mariana Marteleto Carneiro, Leonardo Hoehl de Araujo-Neto, João Marcello Nogueira, Cristiane Alves Villela Ramos-e-Silva, Marcia |
author_sort | Falcão, Eduardo Mastrangelo Marinho |
collection | PubMed |
description | Hepatitis C virus (HCV) chronically infects 0.5–3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effects of these drugs is skin eruption. We report a 53-year-old patient with cirrhosis due to HCV who started the classic treatment associated with telaprevir. In the ninth week, he presented a severe rash that required the interruption of this drug. We emphasize the importance of early recognition and appropriate management of adverse skin reaction. |
format | Online Article Text |
id | pubmed-4612548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-46125482015-10-23 Cutaneous Eruption due to Telaprevir Falcão, Eduardo Mastrangelo Marinho Trope, Beatriz Moritz Godinho, Mariana Marteleto Carneiro, Leonardo Hoehl de Araujo-Neto, João Marcello Nogueira, Cristiane Alves Villela Ramos-e-Silva, Marcia Case Rep Dermatol Published online: September, 2015 Hepatitis C virus (HCV) chronically infects 0.5–3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effects of these drugs is skin eruption. We report a 53-year-old patient with cirrhosis due to HCV who started the classic treatment associated with telaprevir. In the ninth week, he presented a severe rash that required the interruption of this drug. We emphasize the importance of early recognition and appropriate management of adverse skin reaction. S. Karger AG 2015-09-29 /pmc/articles/PMC4612548/ /pubmed/26500538 http://dx.doi.org/10.1159/000439264 Text en Copyright © 2015 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Published online: September, 2015 Falcão, Eduardo Mastrangelo Marinho Trope, Beatriz Moritz Godinho, Mariana Marteleto Carneiro, Leonardo Hoehl de Araujo-Neto, João Marcello Nogueira, Cristiane Alves Villela Ramos-e-Silva, Marcia Cutaneous Eruption due to Telaprevir |
title | Cutaneous Eruption due to Telaprevir |
title_full | Cutaneous Eruption due to Telaprevir |
title_fullStr | Cutaneous Eruption due to Telaprevir |
title_full_unstemmed | Cutaneous Eruption due to Telaprevir |
title_short | Cutaneous Eruption due to Telaprevir |
title_sort | cutaneous eruption due to telaprevir |
topic | Published online: September, 2015 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612548/ https://www.ncbi.nlm.nih.gov/pubmed/26500538 http://dx.doi.org/10.1159/000439264 |
work_keys_str_mv | AT falcaoeduardomastrangelomarinho cutaneouseruptionduetotelaprevir AT tropebeatrizmoritz cutaneouseruptionduetotelaprevir AT godinhomarianamarteleto cutaneouseruptionduetotelaprevir AT carneiroleonardohoehl cutaneouseruptionduetotelaprevir AT dearaujonetojoaomarcello cutaneouseruptionduetotelaprevir AT nogueiracristianealvesvillela cutaneouseruptionduetotelaprevir AT ramosesilvamarcia cutaneouseruptionduetotelaprevir |